Masimo MASI announced today that a new clinical study evaluating Masimo Acoustic Respiration Rate was presented at the New York State Society of Anesthesiologists Annual Post Graduate Assembly Meeting in New York City.
The new study, presented at the 2011 NYPGA, highlights the positive clinical outcomes and patient safety impact of Masimo's unique Acoustic Respiration Rate (RRa™) measurement. Researchers Michael Ramsay, M.D., Elaine Lagow, R.N., and Mohammed Usman, Ph.D., at Baylor University Medical Center in Dallas, Texas, evaluated the accuracy and sensitivity of Masimo RRa and capnography and found that Masimo RRa had higher sensitivity for detecting respiratory pause events compared to capnography.
The study, conducted in 34 post-surgical patients in the post-anesthesia care unit each monitored for an average of 109 minutes, concluded that RRa provided "acceptable respiration rate accuracy" when compared to capnography, but only RRa had the additional advantage of providing "superior sensitivity for detecting respiratory-pause events" defined as no inspiration or expiration activity for > 30 seconds.
MASIMasimo Corp
$163.96-6.05%
Edge Rankings
Momentum92.97
Growth56.51
Quality-
Value16.43
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in